Bijoy Hans appoints Anilkumar as Executive Director for three years

1 min read     Updated on 04 Jul 2026, 12:25 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Bijoy Hans Ltd has appointed Bidari Kotresh Anilkumar as Executive Director for a three-year term effective July 4, 2026, pending shareholder approval. Anilkumar, currently the CEO of SeCURE Hospitals, brings over 12 years of healthcare leadership experience.

powered bylight_fuzz_icon
44692896

*this image is generated using AI for illustrative purposes only.

Bijoy Hans Ltd has appointed Bidari Kotresh Anilkumar as an Executive Director effective July 4, 2026, for a term of three years. The decision was taken by the Board of Directors during a meeting held on Saturday. The appointment is subject to the approval of the company's members through an Ordinary Resolution and the director is liable to retire by rotation.

The Board meeting commenced at 11:30 A.M. IST and concluded at 11:45 A.M. IST. The appointment was based on the recommendation of the Nomination & Remuneration Committee. The company confirmed that Anilkumar is not debarred from holding the office of Director by any order passed by SEBI or other regulatory authorities.

Director Profile

Anilkumar, also known as Dr. Anil Kumar B.K., currently serves as Director and Chief Executive Officer of SeCURE Hospitals. He leads the group's strategic, operational, and business transformation initiatives. He is a medical professional with advanced qualifications in Hospital Administration and possesses over 12 years of leadership experience in healthcare operations, hospital management, and business development.

Prior to joining SeCURE Hospitals, he held senior leadership positions with organizations such as Vaatsalya Hospitals, Cloudnine Hospitals, and Vikram Hospitals. The company disclosed that he is not related to any of the existing directors of the company.

Appointment Details

Detail Information
Name Mr. Bidari Kotresh Anilkumar
DIN 06624790
Designation Executive Director (Additional Director)
Date of Appointment July 4, 2026
Term 3 Years (July 4, 2026 to July 3, 2029)
Shareholder Approval Required via Ordinary Resolution

Historical Stock Returns for Bijoy Hans

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+21.52%+40.64%+70.90%+254.53%+287.42%

How will Anilkumar's healthcare expertise influence Bijoy Hans Ltd's strategic direction?

What operational changes can be expected under Anilkumar's leadership?

Will this appointment lead to diversification into healthcare-related sectors?

Bijoy Hans Limited to Delist from Calcutta Stock Exchange, Retains BSE Listing

1 min read     Updated on 26 Sept 2025, 03:11 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Bijoy Hans Limited plans to voluntarily delist its equity shares from the Calcutta Stock Exchange (CSE) while maintaining its listing on BSE Limited. The decision was approved by the Board of Directors on September 26, 2025. The delisting process will follow SEBI regulations and does not require an exit opportunity for shareholders. The company will continue to trade on BSE, ensuring uninterrupted trading access for investors.

powered bylight_fuzz_icon
20425268

*this image is generated using AI for illustrative purposes only.

Bijoy Hans Limited , a company listed on both the Calcutta Stock Exchange (CSE) and BSE Limited, has announced its intention to voluntarily delist its equity shares from the CSE. This strategic decision was approved by the company's Board of Directors during a meeting held on September 26, 2025.

Key Points of the Delisting Decision

  • The Board of Directors convened on September 26, 2025, from 11:30 AM to 2:30 PM to discuss and approve the delisting proposal.
  • Bijoy Hans Limited will continue to maintain its listing on BSE Limited, which offers nationwide trading terminals.
  • The delisting process is subject to necessary approvals under the Securities and Exchange Board of India (SEBI) (Delisting of Equity Shares) Regulations, 2021.
  • No exit opportunity is required to be provided to the company's shareholders as part of this delisting process.

Implications for Shareholders

The decision to delist from the CSE while retaining the BSE listing suggests that Bijoy Hans Limited is streamlining its market presence. Shareholders should note that their ability to trade the company's shares will not be affected, as the BSE listing will be maintained.

Regulatory Compliance

The company has emphasized that the delisting process will adhere to the applicable provisions of the SEBI (Delisting of Equity Shares) Regulations, 2021. This regulatory framework ensures that the interests of all stakeholders are protected during the delisting process.

Company Information

Bijoy Hans Limited, with the Corporate Identification Number (CIN) L51909AS1985PLC002323, is headquartered at H.P. Brahmachari Road, Rehabari, Kamrup, Guwahati, Assam, India. The company's scrip code on BSE is 524723, and the scrip ID is BITHANS.

Investors and stakeholders can find more information about Bijoy Hans Limited on their website www.bijoyhans.net or contact the company at compliance@arvayahealth.com .

As the delisting process moves forward, shareholders and interested parties are advised to stay informed about any further announcements from the company regarding the necessary approvals and the timeline for the delisting from the Calcutta Stock Exchange.

Historical Stock Returns for Bijoy Hans

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+21.52%+40.64%+70.90%+254.53%+287.42%

More News on Bijoy Hans

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+254.53%